Company · CIK 0001592288 · SIC 2836 — Biological Products, (No Diagnostic Substances)
Dimension Therapeutics, Inc. · DMTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2017 UForm 4 → | Nov 9, 5:01 pm EST | FMR LLCOther | 4,893,322 | $6.00 | $29,359,932 | 0 | — | plan? |
| Nov 7, 2017 DForm 4 → | Nov 7, 5:12 pm EST | Samuel C. WadsworthChief Scientific Officer | 278,035 | — | — | 0 | — | plan? |
| Jun 7, 2016 SForm 4 → | Jun 8, 8:34 pm EDT | K. Reed ClarkSVP of Pharmaceutical Develop | 5,000 | $10.00 | $50,000 | 0 | −100% | plan? |
| Jun 7, 2016 MForm 4 → | Jun 8, 8:34 pm EDT | K. Reed ClarkSVP of Pharmaceutical Develop | 5,000 | $0.38 | $1,900 | 5,000 | — | plan? |
| May 2, 2016 JForm 4 → | May 3, 2:56 pm EDT | FMR LLC10% Owner | 2,106,784 | — | — | 4,893,322 | — | plan? |
| Oct 27, 2015 PForm 4 → | Oct 29, 6:15 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 200,000 | $13.00 | $2,600,000 | 5,397,698 | +3.85% | plan? |
| Oct 27, 2015 CForm 4 → | Oct 29, 6:15 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 5,197,698 | — | — | 5,197,698 | — | plan? |
| Oct 27, 2015 PForm 4 → | Oct 29, 6:14 pm EDT | Rishi GuptaDirector, 10% Owner | 200,000 | $13.00 | $2,600,000 | 5,397,698 | +3.85% | plan? |
| Oct 27, 2015 CForm 4 → | Oct 29, 6:14 pm EDT | Rishi GuptaDirector, 10% Owner | 5,197,698 | — | — | 5,197,698 | — | plan? |
| Oct 27, 2015 PForm 4 → | Oct 29, 6:14 pm EDT | Michael DybbsDirector | 961,538 | $13.00 | $12,499,994 | 2,059,283 | +87.6% | plan? |
| Oct 27, 2015 CForm 4 → | Oct 29, 6:14 pm EDT | Michael DybbsDirector | 1,097,745 | — | — | 1,097,745 | — | plan? |
| Oct 27, 2015 CForm 4 → | Oct 29, 9:28 am EDT | FMR LLC10% Owner | 6,760,627 | — | — | 7,000,106 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2017 DForm 4 → | Nov 7, 5:12 pm EST | Samuel C. WadsworthChief Scientific Officer | 110,000 | — | — | 0 | — | |
| Nov 7, 2017 DForm 4 → | Nov 7, 5:11 pm EST | Mary ThistleChief Operating Officer | 350,630 | — | — | 0 | — | |
| Nov 7, 2017 DForm 4 → | Nov 7, 5:10 pm EST | Arlene MorrisDirector | 93,543 | — | — | 0 | — | |
| Nov 7, 2017 DForm 4 → | Nov 7, 5:09 pm EST | George V MigauskyDirector | 104,841 | — | — | 0 | — | |
| Nov 7, 2017 DForm 4 → | Nov 7, 5:08 pm EST | Annalisa JenkinsPresident and CEO, Director | 1,400,184 | — | — | 0 | — | |
| Nov 7, 2017 DForm 4 → | Nov 7, 5:07 pm EST | John HohnekerDirector | 38,000 | — | — | 0 | — | |
| Nov 7, 2017 DForm 4 → | Nov 7, 5:06 pm EST | Georges GemayelDirector | 93,543 | — | — | 0 | — | |
| Nov 7, 2017 DForm 4 → | Nov 7, 5:06 pm EST | Michael DybbsDirector | 49,069 | — | — | 0 | — | |
| Nov 7, 2017 DForm 4 → | Nov 7, 5:05 pm EST | Eric CrombezChief Medical Officer | 308,688 | — | — | 0 | — | |
| Nov 7, 2017 DForm 4 → | Nov 7, 5:04 pm EST | Alan ColowickDirector | 93,543 | — | — | 0 | — | |
| Jul 3, 2017 AForm 4 → | Jul 5, 5:47 pm EDT | Annalisa JenkinsPresident and CEO, Director | 150,000 | — | — | 150,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 4:47 pm EDT | George V MigauskyDirector | 17,000 | — | — | 17,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 4:32 pm EDT | Georges GemayelDirector | 17,000 | — | — | 17,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 4:30 pm EDT | Michael DybbsDirector | 17,000 | — | — | 17,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 4:28 pm EDT | Alan ColowickDirector | 17,000 | — | — | 17,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 4:28 pm EDT | Arlene MorrisDirector | 17,000 | — | — | 17,000 | — | |
| Feb 1, 2017 AForm 4 → | Feb 3, 4:52 pm EST | Annalisa JenkinsPresident and CEO, Director | 192,000 | — | — | 192,000 | — | |
| Feb 1, 2017 AForm 4 → | Feb 3, 4:43 pm EST | Samuel C. WadsworthChief Scientific Officer | 60,000 | — | — | 60,000 | — | |
| Feb 1, 2017 AForm 4 → | Feb 3, 4:42 pm EST | K. Reed ClarkSVP of Pharmaceutical Develop | 40,000 | — | — | 40,000 | — | |
| Feb 1, 2017 AForm 4 → | Feb 3, 4:40 pm EST | Eric CrombezChief Medical Officer | 50,000 | — | — | 50,000 | — | |
| Feb 1, 2017 AForm 4 → | Feb 3, 4:39 pm EST | Jean M. FranchiChief Financial Officer | 60,000 | — | — | 60,000 | — | |
| Feb 1, 2017 AForm 4 → | Feb 3, 4:36 pm EST | Mary ThistleChief Operating Officer | 60,000 | — | — | 60,000 | — | |
| Jan 18, 2017 AForm 4 → | Jan 20, 5:58 pm EST | John HohnekerDirector | 38,000 | — | — | 38,000 | — | |
| Jun 7, 2016 MForm 4 → | Jun 8, 8:34 pm EDT | K. Reed ClarkSVP of Pharmaceutical Develop | 5,000 | — | — | 114,739 | — | |
| May 19, 2016 AForm 4 → | May 23, 4:39 pm EDT | Arlene MorrisDirector | 32,069 | — | — | 32,069 | — | |
| May 19, 2016 AForm 4 → | May 23, 4:39 pm EDT | George V MigauskyDirector | 32,069 | — | — | 32,069 | — | |
| May 19, 2016 AForm 4 → | May 23, 4:38 pm EDT | Rishi GuptaDirector | 32,069 | — | — | 32,069 | — | |
| May 19, 2016 AForm 4 → | May 23, 4:37 pm EDT | Georges GemayelDirector | 32,069 | — | — | 32,069 | — | |
| May 19, 2016 AForm 4 → | May 23, 4:36 pm EDT | Michael DybbsDirector | 32,069 | — | — | 32,069 | — | |
| May 19, 2016 AForm 4 → | May 23, 4:34 pm EDT | Alan ColowickDirector | 32,069 | — | — | 32,069 | — | |
| Feb 1, 2016 AForm 4 → | Feb 2, 6:53 pm EST | Samuel C. WadsworthChief Scientific Officer | 50,000 | — | — | 50,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 2, 6:47 pm EST | Mary ThistleChief Business Officer | 65,000 | — | — | 65,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 2, 6:46 pm EST | Eric CrombezChief Medical Officer | 50,000 | — | — | 50,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 2, 6:45 pm EST | K. Reed ClarkSee Remarks | 25,000 | — | — | 25,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 2, 6:45 pm EST | Annalisa JenkinsPresident & CEO, Director | 160,000 | — | — | 160,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 2, 6:42 pm EST | Jean M. FranchiChief Financial Officer | 50,000 | — | — | 50,000 | — | |
| Oct 27, 2015 CForm 4 → | Oct 29, 6:15 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 15,192,874 | — | — | 0 | — | |
| Oct 27, 2015 CForm 4 → | Oct 29, 6:14 pm EDT | Rishi GuptaDirector, 10% Owner | 15,192,874 | — | — | 0 | — | |
| Oct 27, 2015 CForm 4 → | Oct 29, 6:14 pm EDT | Michael DybbsDirector | 3,208,711 | — | — | 0 | — | |
| Oct 27, 2015 CForm 4 → | Oct 29, 9:28 am EDT | FMR LLC10% Owner | 19,761,313 | — | — | 0 | — |